Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithm - author's reply.
Division of Digestive Endoscopy, Shiga University of Medical Science Hospital, Shiga, Japan. sugimo@belle.shiga-med.ac.jp.
M
M
Sugimoto
D005260:Female; D024841:Fluoroquinolones / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D064750:Rabeprazole / Q000627:therapeutic use*
D024841:Fluoroquinolones; D008795:Metronidazole; D064750:Rabeprazole